Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 23510 | 343 | 32.0 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 427 | 3 | JOURNAL OF THE INSTITUTE OF BREWING//KERATINASE//CYSTATIN | 27946 |
| 2592 | 2 | JOURNAL OF THE INSTITUTE OF BREWING//MALTING//BROMELAIN | 3632 |
| 23510 | 1 | BROMELAIN//CORN MALT//BROMELAINE | 343 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | BROMELAIN | authKW | 3721730 | 29% | 41% | 101 |
| 2 | CORN MALT | authKW | 356095 | 1% | 100% | 4 |
| 3 | BROMELAINE | authKW | 267071 | 1% | 100% | 3 |
| 4 | ORAL ENZYME PREPARATION | authKW | 267071 | 1% | 100% | 3 |
| 5 | FRUIT BROMELAIN | authKW | 200302 | 1% | 75% | 3 |
| 6 | PROTEINASE THERAPY | authKW | 200302 | 1% | 75% | 3 |
| 7 | AMBERLITE IRA 410 ION EXCHANGE RESIN | authKW | 178047 | 1% | 100% | 2 |
| 8 | ANTIMICROBIAL ENZYMOTHERAPY ENZYMOPROPHYLAXIS | authKW | 178047 | 1% | 100% | 2 |
| 9 | BROMELAIN F9 | authKW | 178047 | 1% | 100% | 2 |
| 10 | ENGN CHEM SYST DESQ | address | 178047 | 1% | 100% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Integrative & Complementary Medicine | 1198 | 7% | 0% | 25 |
| 2 | Pharmacology & Pharmacy | 280 | 19% | 0% | 64 |
| 3 | Immunology | 199 | 13% | 0% | 45 |
| 4 | Oncology | 93 | 10% | 0% | 36 |
| 5 | Chemistry, Medicinal | 90 | 6% | 0% | 19 |
| 6 | Food Science & Technology | 82 | 7% | 0% | 23 |
| 7 | Biology | 79 | 5% | 0% | 17 |
| 8 | Medicine, Research & Experimental | 77 | 7% | 0% | 23 |
| 9 | Biotechnology & Applied Microbiology | 66 | 7% | 0% | 25 |
| 10 | Rheumatology | 56 | 3% | 0% | 9 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ENGN CHEM SYST DESQ | 178047 | 1% | 100% | 2 |
| 2 | IMMUNOSTIMULANTS GRP | 178047 | 1% | 100% | 2 |
| 3 | ENGN SISTEMAS QUIM | 116263 | 2% | 16% | 8 |
| 4 | BIOPROC MOL ENGN UNIT | 100148 | 1% | 38% | 3 |
| 5 | ABT PHARMAZEUT BIOCHEM MOL BIOL BIOTECHNOL | 89024 | 0% | 100% | 1 |
| 6 | ABT REHABILITAT PRAVENT SPORTSMED | 89024 | 0% | 100% | 1 |
| 7 | ADM PROC IND QUIM | 89024 | 0% | 100% | 1 |
| 8 | CLIN HAEMATOL TRANSFUS MED | 89024 | 0% | 100% | 1 |
| 9 | EIJKMAN WINKLER MICROBIOL INFEST DIS INFLA | 89024 | 0% | 100% | 1 |
| 10 | ENGN PROC HIDRAUL | 89024 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 68196 | 6% | 4% | 19 |
| 2 | BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY | 7347 | 4% | 1% | 14 |
| 3 | ACTA SCIENTIARUM-TECHNOLOGY | 3922 | 1% | 1% | 5 |
| 4 | CANCER BIOTHERAPY | 3744 | 1% | 2% | 2 |
| 5 | BIOTECH FORUM EUROPE | 2780 | 0% | 3% | 1 |
| 6 | INTEGRATIVE CANCER THERAPIES | 1713 | 1% | 1% | 3 |
| 7 | CUSTOS E AGRONEGOCIO | 1368 | 0% | 2% | 1 |
| 8 | ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE | 1043 | 1% | 0% | 3 |
| 9 | TROPICAL PLANT BIOLOGY | 966 | 0% | 1% | 1 |
| 10 | CIENCIA E TECNOLOGIA DE ALIMENTOS | 851 | 1% | 0% | 3 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BROMELAIN | 3721730 | 29% | 41% | 101 | Search BROMELAIN | Search BROMELAIN |
| 2 | CORN MALT | 356095 | 1% | 100% | 4 | Search CORN+MALT | Search CORN+MALT |
| 3 | BROMELAINE | 267071 | 1% | 100% | 3 | Search BROMELAINE | Search BROMELAINE |
| 4 | ORAL ENZYME PREPARATION | 267071 | 1% | 100% | 3 | Search ORAL+ENZYME+PREPARATION | Search ORAL+ENZYME+PREPARATION |
| 5 | FRUIT BROMELAIN | 200302 | 1% | 75% | 3 | Search FRUIT+BROMELAIN | Search FRUIT+BROMELAIN |
| 6 | PROTEINASE THERAPY | 200302 | 1% | 75% | 3 | Search PROTEINASE+THERAPY | Search PROTEINASE+THERAPY |
| 7 | AMBERLITE IRA 410 ION EXCHANGE RESIN | 178047 | 1% | 100% | 2 | Search AMBERLITE+IRA+410+ION+EXCHANGE+RESIN | Search AMBERLITE+IRA+410+ION+EXCHANGE+RESIN |
| 8 | ANTIMICROBIAL ENZYMOTHERAPY ENZYMOPROPHYLAXIS | 178047 | 1% | 100% | 2 | Search ANTIMICROBIAL+ENZYMOTHERAPY+ENZYMOPROPHYLAXIS | Search ANTIMICROBIAL+ENZYMOTHERAPY+ENZYMOPROPHYLAXIS |
| 9 | BROMELAIN F9 | 178047 | 1% | 100% | 2 | Search BROMELAIN+F9 | Search BROMELAIN+F9 |
| 10 | FERMOSORB | 178047 | 1% | 100% | 2 | Search FERMOSORB | Search FERMOSORB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MANZOOR, Z , NAWAZ, A , MUKHTAR, H , HAQ, I , (2016) BROMELAIN: METHODS OF EXTRACTION, PURIFICATION AND THERAPEUTIC APPLICATIONS.BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY. VOL. 59. ISSUE . P. - | 39 | 51% | 0 |
| 2 | NOVAES, LCD , JOZALA, AF , LOPES, AM , SANTOS-EBINUMA, VD , MAZZOLA, PG , PESSOA, A , (2016) STABILITY, PURIFICATION, AND APPLICATIONS OF BROMELAIN: A REVIEW.BIOTECHNOLOGY PROGRESS. VOL. 32. ISSUE 1. P. 5 -13 | 32 | 53% | 1 |
| 3 | CHOBOTOVA, K , VERNALLIS, AB , MAJID, FAA , (2010) BROMELAIN'S ACTIVITY AND POTENTIAL AS AN ANTI-CANCER AGENT: CURRENT EVIDENCE AND PERSPECTIVES.CANCER LETTERS. VOL. 290. ISSUE 2. P. 148-156 | 35 | 49% | 50 |
| 4 | LOPES, FLG , SBRUZZI, D , BARROS, KVG , FERREIRA, JF , SANTANA, JCC , DE SOUZA, RR , TAMBOURGI, EB , (2012) VIABILITY IN THE PRODUCTION OF A DRUG EXTRACTED FROM ANANAS COMOSUS BY A FLAT MEMBRANE SYSTEM.BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY. VOL. 55. ISSUE 3. P. 465-470 | 14 | 100% | 1 |
| 5 | FITZHUGH, DJ , SHAN, SQ , DEWHIRST, MW , HATE, LP , (2008) BROMELAIN TREATMENT DECREASES NEUTROPHIL MIGRATION TO SITES OF INFLAMMATION.CLINICAL IMMUNOLOGY. VOL. 128. ISSUE 1. P. 66-74 | 19 | 76% | 23 |
| 6 | MAURER, HR , (2001) BROMELAIN: BIOCHEMISTRY, PHARMACOLOGY AND MEDICAL USE.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 58. ISSUE 9. P. 1234 -1245 | 24 | 59% | 201 |
| 7 | HALE, LP , GREER, PK , TRINH, CT , JAMES, CL , (2005) PROTEINASE ACTIVITY AND STABILITY OF NATURAL BROMELAIN PREPARATIONS.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 5. ISSUE 4. P. 783-793 | 18 | 78% | 69 |
| 8 | LOURENCO, CB , ATAIDE, JA , CEFALI, LC , NOVAES, LCDL , MORIEL, P , SILVEIRA, E , TAMBOURGI, EB , MAZZOLA, PG , (2016) EVALUATION OF THE ENZYMATIC ACTIVITY AND STABILITY OF COMMERCIAL BROMELAIN INCORPORATED IN TOPICAL FORMULATIONS.INTERNATIONAL JOURNAL OF COSMETIC SCIENCE. VOL. 38. ISSUE 5. P. 535 -540 | 15 | 71% | 0 |
| 9 | MULLER, A , BARAT, S , CHEN, X , BUI, KC , BOZKO, P , MALEK, NP , PLENTZ, RR , (2016) COMPARATIVE STUDY OF ANTITUMOR EFFECTS OF BROMELAIN AND PAPAIN IN HUMAN CHOLANGIOCARCINOMA CELL LINES.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 48. ISSUE 5. P. 2025 -2034 | 19 | 56% | 0 |
| 10 | PILLAI, K , AKHTER, J , CHUA, TC , MORRIS, DL , (2013) ANTICANCER PROPERTY OF BROMELAIN WITH THERAPEUTIC POTENTIAL IN MALIGNANT PERITONEAL MESOTHELIOMA.CANCER INVESTIGATION. VOL. 31. ISSUE 4. P. 241-250 | 37 | 28% | 6 |
Classes with closest relation at Level 1 |